(Total Views: 493)
Posted On: 05/15/2017 7:45:01 PM
Post# of 72446
Post by Biotechmaven over there:
Quote:
BioTechMaven Monday, 05/15/17 06:50:42 PM
Re: Waverunner1 post# 182136
Post # of 182142
Correct. $100M in the face of a history of deals with small bio's and big pharma in the billions, coupled with the fact that CTIX's drugs are posting better results, and in some cases the only results (OM), positions the company extremely well. Again, if CTIX was trading today on NASDAQ I think a fair valuation would be $1B. On the OTC, $500M today is realistic heading into 4 mid phase topline reveals in 2017.
It's just a matter of time and patience before any of the following scenarios occur:
1. Partnership one one or several drugs from one or multiple big pharma.
2. Outright acquisition of one drug.
3. Outright acquisition of entire company.
I'm wagering there's no chance we crest into 2018 without one of these scenarios happening.
Good luck to all in assembling or maintaining your positions in the face of likely increased crazy attention as the share price continues to rise.
(1)
(0)
